Mark P. Colonnese

Chief Financial Officer, Vaxart.

Companies

BIO-PATH HOLDINGS, INC.Board member Jul 17, 2017 to Apr 1, 2019¹
VaxartChief financial officer Nov 3, 2015 to Apr 5, 2017²
Precipio, Inc.Chief financial officer Sep 17, 2012 to Feb 20, 2014³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vaxart VXRT7,000 shares⁴$3.2K at $0.46Feb 9, 2016

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 9, 2016Bought 6,700 shares at $1.41 of Vaxart⁴
Feb 9, 2016Bought 300 shares at $1.40 of Vaxart⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBIO-PATH HOLDINGS, INC., Board member
2
SEC EDGARVaxart, Chief financial officer
3
SEC EDGARPrecipio, Inc., Chief financial officer
4
SEC EDGARVaxart shares after the filing of Feb 9, 2016